 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/11/2024 |
$1.61 |
$1.61 |
$1.52 |
$1.56 |
123.00K | | 04/12/2024 |
$1.60 |
$1.62 |
$1.50 |
$1.53 |
155.50K | | 04/15/2024 |
$1.53 |
$1.54 |
$1.41 |
$1.47 |
69.40K | | 04/16/2024 |
$1.44 |
$1.51 |
$1.36 |
$1.47 |
91.60K | | 04/17/2024 |
$1.50 |
$1.51 |
$1.36 |
$1.36 |
112.50K |
|
|
| Corvus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of immune modulator product candidates to treat solid cancers, T-cell lymphomas, autoimmune diseases and infectious diseases. Co.'s lead product candidate is mupadolimab, a humanized monoclonal antibody that is designed to react with a specific site on CD73. Co.'s next product candidate, CPI-818, is a selective, covalent inhibitor of ITK and is in a multi-center Phase 1/1b clinical trial in patients with various malignant T-cell lymphomas. Co.'s third product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine. | |
|
Corvus Pharmaceuticals (CRVS) has the following price history information. Looking back at CRVS historical stock prices for the last five trading days, on April 11, 2024, CRVS opened at $1.61, traded as high as $1.61 and as low as $1.52, and closed at $1.56. Trading volume was a total of 123.00K shares. On April 12, 2024, CRVS opened at $1.60, traded as high as $1.62 and as low as $1.50, and closed at $1.53. Trading volume was a total of 155.50K shares. On April 15, 2024, CRVS opened at $1.53, traded as high as $1.54 and as low as $1.41, and closed at $1.47. Trading volume was a total of 69.40K shares. On April 16, 2024, CRVS opened at $1.44, traded as high as $1.51 and as low as $1.36, and closed at $1.47. Trading volume was a total of 91.60K shares. On April 17, 2024, CRVS opened at $1.50, traded as high as $1.51 and as low as $1.36, and closed at $1.36. Trading volume was a total of 112.50K shares.
CRVS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Corvus Pharmaceuticals shares, starting with a $10,000 purchase of CRVS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/24/2016 |
|
| End date: |
04/17/2024 |
|
| Start price/share: |
$14.25 |
|
| End price/share: |
$1.36 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-90.46% |
|
| Average Annual Total Return: |
-25.25% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$954.74 |
|
| Years: |
8.07 |
|
|
|
| Date |
Close |
| 04/11/2024 | $1.56 | | 04/12/2024 | $1.53 | | 04/15/2024 | $1.47 | | 04/16/2024 | $1.47 | | 04/17/2024 | $1.36 |
|
|
Free CRVS Email Alerts:
